Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HTR2A | P28223 | 4/20 | 0.52 |
| ▸ | HRH1 | P35367 | 4/20 | 0.52 |
| ▸ | AOC3 | Q16853 | 7/20 | 0.52 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.50 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.50 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.48 |
| ▸ | SLC6A2 | P23975 | 3/20 | 0.45 |
| ▸ | SLC6A4 | P31645 | 3/20 | 0.45 |
| ▸ | LMNA | P02545 | 2/20 | 0.45 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.45 |
| ▸ | CHRM2 | P08172 | 1/20 | 0.45 |
| ▸ | CHRM4 | P08173 | 1/20 | 0.45 |
| ▸ | CHRM5 | P08912 | 1/20 | 0.45 |
| ▸ | ADRA2A | P08913 | 1/20 | 0.45 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.45 |
| ▸ | CHRM1 | P11229 | 1/20 | 0.45 |
| ▸ | TSHR | P16473 | 1/20 | 0.45 |
| ▸ | ADRA2B | P18089 | 1/20 | 0.45 |
| ▸ | CHRM3 | P20309 | 1/20 | 0.45 |
| ▸ | HRH2 | P25021 | 1/20 | 0.45 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2453015 | 0.92 | AOC3 (0.47) | HTR2AHRH1AOC3KDM4EALDH1A1 | |
| SCHEMBL10125298 | 0.87 | KDM4E (0.50) | HTR2AHRH1AOC3KDM4EALDH1A1 | |
| SCHEMBL22725637 | 0.87 | KDM4E (0.50) | HTR2AHRH1AOC3KDM4EALDH1A1 | |
| Hydrochloric Acid SCHEMBL14764229 | 0.85 | ALDH1A1 (0.48) | HTR2AHRH1AOC3KDM4EALDH1A1 | |
| SCHEMBL19658275 | 0.83 | AOC3 (0.70) | HTR2AAOC3KDM4EALDH1A1SLC6A2 | |
| SCHEMBL21340477 | 0.83 | AOC3 (0.70) | HTR2AAOC3KDM4EALDH1A1SLC6A2 | |
| SCHEMBL6920099 | 0.83 | DPP4 (0.56) | HTR2AHRH1AOC3KDM4EALDH1A1 | |
| SCHEMBL6580072 | 0.83 | AOC3 (0.70) | HTR2AAOC3KDM4EALDH1A1SLC6A2 | |
| SCHEMBL11353001 | 0.83 | AOC3 (0.70) | HTR2AAOC3KDM4EALDH1A1SLC6A2 | |
| SCHEMBL17571131 | 0.83 | AOC3 (0.53) | HTR2AHRH1AOC3KDM4EALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11691136-B2 | Olefin oligomerization catalyst and method for producing olefin oligomer in the presence of the same catalyst | MITSUI CHEMICALS, INC. (JP) | 2023-07-04 | — | — | US | disclosed |
| US-11691136-B2 | Olefin oligomerization catalyst and method for producing olefin oligomer in the presence of the same catalyst | MITSUI CHEMICALS, INC. (JP) | 2023-07-04 | — | — | US | disclosed |
| US-20200222886-A1 | OLEFIN OLIGOMERIZATION CATALYST AND METHOD FOR PRODUCING OLEFIN OLIGOMER IN THE PRESENCE OF THE SAME CATALYST | MITSUI CHEMICALS, INC. (JP) | 2020-07-16 | — | — | US | disclosed |
| EP-0803510-B1 | 2,2'-Disubstituted 1,1'-diphosphino ferrocenes and 1',2-disubstituted 1-phosphino ferrocenes, their preparation and use and transition metal complexes containing them | HOECHST AG (DE) | 2002-09-11 | — | — | EP | disclosed |
| US-5856540-A | 2,2'-disubtituted 1,1'-diphosphino-ferrocenes and 1',2-disubstituted 1-phosphino-ferrocenes, processes for preparing them, their use, and transition metal complexes comprising them | HOECHST AKTIENGESELLSCHAFT (DE) | 1999-01-05 | — | — | US | disclosed |
| EP-0803510-A1 | 2,2'-Disubstituted 1,1'-diphosphino ferrocenes and 1',2'-disubstituted 1-phosphino ferrocenes, their preparation and use and transition metal complexes containing them | HOECHST AKTIENGESELLSCHAFT (DE) | 1997-10-29 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20200222886-A1 | OLEFIN OLIGOMERIZATION CATALYST AND METHOD FOR PRODUCING OLEFIN OLIGOMER IN THE PRESENCE OF THE SAME CATALYST | OXER1, COG6, CBR1 | HTR2A 1012/4885HRH1 148/4885AOC3 19/4885 |
| US-11691136-B2 | Olefin oligomerization catalyst and method for producing olefin oligomer in the presence of the same catalyst | OXER1, COG6, CBR1 | HTR2A 1012/4885HRH1 148/4885AOC3 19/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.